期刊文献+

护骨素基因多态性对青春前期女童骨量的影响

EFFECT OF OSTEOPROTEGERIN GENE POLYMORPHISM ON BONE MASS IN PREMENARCHE GIRLS
下载PDF
导出
摘要 目的:了解护骨素(osteoprotegerin,OPG)基因启动子区A163G、T245G和T950C位点多态性对青春前期汉族女童骨密度(BMD)的影响。方法:采用PCR-RFLP技术检测广州地区214名青春前期女童护骨素基因三个位点的基因型。采用双能X线骨密度仪测量全身、腰椎(L1-4)、股骨颈和Ward三角区骨矿含量(BMC)和骨密度。同时测定三种骨代谢生化指标。结果:OPG基因启动子区A163G、T245G和T950C位点基因型分布频率均符合Hardy-Weinberg遗传平衡定律,分布频率分别为:A163G:AA-74.8%,AG-21.5%,GG-3.7%;T245G:TT-77.1%,TG-21.5%,GG-1.4%;T950C:TT-41.1%,TC-50.5%,CC-8.4%。T950C位点CC基因型女童的全身骨量、骨密度及股骨颈和Ward三角区骨密度均显著高于TT、TC基因型女童(P<0.05),而TT和TC基因型女童未见显著差异(P>0.05)。A163G和T245G位点多态性与女童BMC和BMD的相关性未发现有统计学意义(P>0.05)。结论:护骨素基因T950C位点含有T等位基因的青春前期女童,其全身骨密度及股骨颈和Ward’s三角区骨密度均较低,该等位基因可能为我国青春期女童低骨量者筛选的遗传学标志提供了研究方向。 Objective: To investigate the effects of promoter region A163G,T245G and T950C polymorphisms of osteoprotegerin (OPG) gene on bone mineral density (BMD) in premenarche girls. Method: The OPG genotypes were determined by PCR-RFLP in 214 premenarche girls of Han nationality in Guangzhou area , and BMC and BMD at lumbar spine(L1-4), femoral neck, Ward’s triangle area and total BMD were measured by dual-energy X-ray absorptiometry(DEXA). Three markers of bone turnover were also detected. Results: Hardy-Weinberg equilibrium was evident for OPG polymorphisms. The frequency of three genotypes were as following:A163G:AA-74.8%,AG-21.5%,GG-3.7%;T245G:TT-77.1%, TG-21.5%,GG-1.4%;T950C:TT-41.1%,TC-50.5%,CC-8.4%. The girls with CC genotype had higher BMD at femoral neck , Ward’s triangle area and total BMD than those with TC or TT genotypes. Such difference was not detected between girls with TC genotype and those with TT genotype. Significant link was not observed between A163G、T245G polymorphism with BMD. Conclusion: The premenarche girls with T allele may have lower BMD at femoral neck , Ward’s triangle area and total BMD. The results mayprovide scientific basis for further determining a valuable genetic marker for low bone mass in premenarche girls.
出处 《营养学报》 CAS CSCD 北大核心 2007年第4期359-363,共5页 Acta Nutrimenta Sinica
基金 国家自然科学基金(No.30571569)
关键词 OPG PCR-RFLP 基因多态性 骨密度 OPG PCR-RFLP polymorphism bone mineral density
  • 相关文献

参考文献14

  • 1Simonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin a novel secreted protein involved in the regulation of bone density[J].Cell,1997,89:309-319.
  • 2Mizuno A,Amizuka N,Irie K,et al.Severe oeteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin[J].Biochem Biophys Res Commun,1998,247:610-615.
  • 3Bucay N,Sarosi I,Dunstan CR,et al.Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification[J].Genes Dev,1998,12:1260-1268.
  • 4Rizzoli R,Bonjour JP.Determinants of peak bone mineral mass and mechanisms of bone loss[J].Osteopor Int,1999,9(suppl2):S17-S23.
  • 5Hui SL,Slemenda CW,Johnston CC.The contribution of bone loss to postmenopausal osteoporosis[J].Osteoporos Int,1990,1:30-34.
  • 6Kelly PJ,Morrison NA,Sambrook PN,et al.Genetic influences on bone turnover,bone density and fracture[J].Eur J Endocinol,1995,133:265-271.
  • 7杨晓光,李艳平,马冠生,胡小琪,王京钟,崔朝辉,王志宏,于文涛,杨正雄,翟凤英.中国2002年居民身高和体重水平及近10年变化趋势分析[J].中华流行病学杂志,2005,26(7):489-493. 被引量:83
  • 8Langdahl BL,Carstens M,Stenkjaer L,et al.Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures[J].J Bone Miner Res,2002,17:1245-1255.
  • 9中国人原发性骨质疏松症诊断标准(试行)[J].中国骨质疏松杂志,1999,5(F03):1-3. 被引量:325
  • 10Arko B,Prezelj K,Komel R,et al.Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis[J].J Clin Endocrinol Metab,2002,87:4080-4084.

二级参考文献26

  • 1杨晓光,孔灵芝,翟凤英,马冠生,金水高,中国居民营养与健康状况调查技术执行组.中国居民营养与健康状况调查的总体方案[J].中华流行病学杂志,2005,26(7):471-474. 被引量:174
  • 2Simonet WS, Lacey DL, Dunstan CR, et al . Osteoprotegerm: a novel secreted protein involved in the regulation of bone density[J].Cell,1997;589: 309-19.
  • 3Yasuda H, Shima N, Nakagawa N, et al . Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro[J]. Endocrinology,1998;139:1329-37.
  • 4Lacey DL, Timms E, Tan HL, et al . Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[J].Cell,1998;93:165-76.
  • 5Yasuda H, Shima N, Nakagawa N,et al . Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoelastogenesis-inhibitory factor and is identical to TRANCE/RANKL[J]. Proc Natl Acad Sci USA,1998;95:3597-602.
  • 6Langdahl BL, Carstens M, Stenkjaer L, et al . Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures[J]. J Bone Miner Res 2002;17(7): 1245-55.
  • 7Morinaga T, Nakagawa N, Yasuda H, et al . Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor[J].Eur J Biochem,1998;254:685-91.
  • 8Kanis J, Melton I, Christiansen C, et al . The diagnosis of osteoporosis[J].J Bone Miner Res,1994;9:1137-41.
  • 9Morrison NA, Qi JC, Tokita A, et al . Prediction of bone density from vitamin D receptor alleles[J].Nature, 1994;367;284-7.
  • 10Kelly PJ, Morrison NA, Sambrook PN, et al. Genetic influences on bone turnover, bone density and fracture[J].Eur J Endocrinol, 1995;133:265- 71.

共引文献427

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部